期刊文献+

宫颈癌的发病机制及中医药治疗研究进展 被引量:10

The Pathogenesis of Uterine Cervix Cancer and Its Therapeutic Progress of TCM
下载PDF
导出
摘要 文章从病毒感染,细胞周期调节,端粒、端粒酶,雌、孕激素与宫颈癌之间的关系探讨了宫颈癌的发病机制。认为扶正祛邪是中医治疗本病的根本原则,根据临床症状辨证论治,运用中药内服及外治对宫颈癌有一定治疗优势。 The paper investigated the pathogenesis of uterine cervix cancer from the relationship between uterine cervix cancer and viral infection, regulation of cell cycle, telomere and telomerase, estrogen and pregnancy hormone. Strengthening healthy qi to eliminate pathogens was considered the principle to treat this disease with TCM, according to clinical symptoms and signs for treating nterine cervix cancer by taking Chinese crude drugs orally together with external therapy, there were certain therapeutic superiority.
作者 关素洁
出处 《中医药导报》 2007年第2期95-96,107,共3页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
关键词 宫颈癌 中医药疗法 综述 Uterine Cervix Cancer Theraoeutic methods of TCM Summarization
  • 相关文献

参考文献14

  • 1Counter CM,Hirte HW,Bacchetti S,et al.Proc.Natl.Acad.Sci.USA.1994(91):2900
  • 2洪文旭.子宫颈癌的中医治疗近况[J].国医论坛,1989,4(1):39-40. 被引量:4
  • 3李新英,糜若然,焦书竹,岳天孚.宫颈癌HPV型别与预后的关系[J].实用妇产科杂志,1999,15(6):309-310. 被引量:12
  • 4Ohwada M,Suzuki M,Kashiwagi H,et al.DNA replication error in endometrial carcinoma and complex atypical endometrial hyperplasia[J].Cancer Genet Cytogenet,1999,114(2):130
  • 5Ulaner GA,Hu JF,Vu TH,et al.Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase(hTERT)in normal and neoplastic ovary,endometrium and muometrium.Int.J.Cancer,2000(85):330
  • 6Klxwlik TF,DeGregpro J,Leone G,et al.E2F1-specific induction of apoptosis and p53 accumulation,which is blocked by mdm2[J].Cell Growth Differ,1998(9):113
  • 7Markman M,Rose PG,Jones E,et al.Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues[J].Cancer Lett,2000,151(2):127
  • 8Comerci JT Jr,Runowicz CD,Fields AL.et al.Induction of transforming growth factor beta-1 in cervical intraepithelial neoplasia in vivo after treatment with betacarotene[J].Clin Cancer Res,1997,3(2):157
  • 9Lu W,Pochampally R,Chen L,et al.Nucle exclusion of p53 in a subset of tumors requires mdm2 function[J].Oncogene,2000(18):232
  • 10Kyo S,Takakura M,Kohama T,et al.Telomerase activity in human endometrium[J].Cancer Res,1997(11):1681

二级参考文献2

  • 1陈耿生 张链.子宫颈癌病理类型及间质反应与预后的关系[J].中华妇产科杂志,1983,18:91-91.
  • 2李超荆,徐亚铭,孙月丽,归绥琪,瞿霞仙,丁声颂,伍焜贤,楼贤鸿,刘星堦,林云福.掌叶半夏抗子宫颈癌成份的研究 Ⅱ.β-谷甾醇的分离、鉴定及疗效观察[J]上海第一医学院学报,1981(06).

共引文献25

同被引文献78

引证文献10

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部